Page last updated: 2024-08-22

platinum and Uterine Neoplasms

platinum has been researched along with Uterine Neoplasms in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19901 (11.11)18.7374
1990's3 (33.33)18.2507
2000's2 (22.22)29.6817
2010's0 (0.00)24.3611
2020's3 (33.33)2.80

Authors

AuthorsStudies
Chang, WH; Chen, YJ; Huang, HY; Lee, NR; Lin, SC; Su, MH; Wang, PH; Wu, HH1
Fu, HC; Huang, YC; Kao, CH; Lan, J; Lin, H; Liu, CT; Ou, YC; Wu, CH1
Barker, HE; Barnett, S; Bedő, J; Caldwell, R; Carmagnac, A; Collins, IM; Dall, G; Dobrovic, A; Fox, SB; Grimmond, S; Hamilton, A; Hofmann, O; Kee, D; Klein, O; Kyran, EL; Lim, R; Lobley, A; McNally, O; Meniawy, T; Milesi, B; Nesic, K; Ng, AP; Nugawela, D; O'Grady, E; Olesen, I; Papadopoulos, L; Papenfuss, AT; Penington, J; Power, JD; Ratnayake, G; Scott, CL; Shield-Artin, K; Stewart, KP; Tan, TH; Tram, J; Vandenberg, CJ; Vissers, JHA; Wakefield, MJ; Zhou, W; Zhu, W1
Axtell, AE; Drake, RD; Fader, AN; Gehrig, PA; Gibbons, HE; Havrilesky, LJ; Huh, WK; O'Malley, DM; Tuller, E; Zanotti, KM1
Chen, JT; Hasumi, K1
Jones, WB; Lewis, JL; Schneider, J; Shapiro, F1
Hamana, S; Ku, Y; Maruo, T; Miyahara, Y; Motoyama, S; Takeuchi, S; Tateiwa, Y; Yoshida, S1
Bakri, YN; Ezzat, A; Pedersen, P1
Kamitani, N; Matsumoto, S; Mori, T; Shimoyama, N; Tateyama, I; Tominaga, T1

Trials

2 trial(s) available for platinum and Uterine Neoplasms

ArticleYear
[Pharmacokinetic analysis of platinum in the continuous CDDP-CBDCA treatment; its relation to the changes of blood biochemistry].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1995, Volume: 22, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Carboplatin; Cisplatin; Creatinine; Drug Administration Schedule; Endometrial Neoplasms; Female; Humans; Infusions, Intravenous; Platinum; Uterine Neoplasms

1995
Super high-dose intraarterial cisplatin infusion under percutaneous pelvic perfusion with extracorporeal chemofiltration for advanced uterine cervical carcinoma: I. Analysis for pharmacokinetics, tumor response, and toxicity of platinum.
    American journal of clinical oncology, 2001, Volume: 24, Issue:3

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Chemotherapy, Cancer, Regional Perfusion; Cisplatin; Feasibility Studies; Female; Humans; Infusions, Intra-Arterial; Middle Aged; Neoplasm Staging; Platinum; Uterine Neoplasms

2001

Other Studies

7 other study(ies) available for platinum and Uterine Neoplasms

ArticleYear
Comparing paclitaxel-platinum with ifosfamide-platinum as the front-line chemotherapy for patients with advanced-stage uterine carcinosarcoma.
    Journal of the Chinese Medical Association : JCMA, 2022, 02-01, Volume: 85, Issue:2

    Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Female; Humans; Ifosfamide; Middle Aged; Paclitaxel; Platinum; Postoperative Period; Retrospective Studies; Uterine Neoplasms

2022
Case report: Durable response after pembrolizumab in combination with radiation - induced abscopal effect in platinum - refractory metastatic endometrial clear cell carcinoma.
    Frontiers in immunology, 2022, Volume: 13

    Topics: Antibodies, Monoclonal, Humanized; Carcinoma; Female; Humans; Platinum; Uterine Neoplasms

2022
Targeting homologous recombination deficiency in uterine leiomyosarcoma.
    Journal of experimental & clinical cancer research : CR, 2023, May-04, Volume: 42, Issue:1

    Topics: Female; Homologous Recombination; Humans; Leiomyosarcoma; Ovarian Neoplasms; Piperazines; Platinum; Poly(ADP-ribose) Polymerases; Recombinational DNA Repair; Uterine Neoplasms

2023
Platinum/taxane-based chemotherapy with or without radiation therapy favorably impacts survival outcomes in stage I uterine papillary serous carcinoma.
    Cancer, 2009, May-15, Volume: 115, Issue:10

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; Combined Modality Therapy; Cystadenocarcinoma, Papillary; Disease-Free Survival; Female; Humans; Platinum; Recurrence; Retrospective Studies; Taxoids; Uterine Neoplasms

2009
Treatment of resistant gestational choriocarcinoma with taxol: a report of two cases.
    Gynecologic oncology, 1996, Volume: 61, Issue:1

    Topics: Adult; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Choriocarcinoma; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Drug Resistance, Neoplasm; Etoposide; Female; Frontal Lobe; Humans; Liver Neoplasms; Lung Neoplasms; Methotrexate; Middle Aged; Paclitaxel; Platinum; Pregnancy; Pregnancy Complications, Neoplastic; Uterine Neoplasms; Vincristine

1996
Metastatic choriocarcinoma with coexistent term pregnancy following four recurrent consecutive moles.
    Acta obstetricia et gynecologica Scandinavica, 1992, Volume: 71, Issue:5

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Hydatidiform Mole; Lung Neoplasms; Methotrexate; Platinum; Pregnancy; Pregnancy Complications, Neoplastic; Uterine Neoplasms

1992
[Selective intra-arterial administration of a high dose of CDDP in combination with plasmapheresis].
    Nihon Gan Chiryo Gakkai shi, 1988, Apr-20, Volume: 23, Issue:4

    Topics: Cisplatin; Combined Modality Therapy; Female; Humans; Injections, Intra-Arterial; Middle Aged; Plasmapheresis; Platinum; Uterine Neoplasms

1988